Quantel Medical SAS
Quantel Medical SAS, headquartered in France, is a leading player in the medical technology industry, specialising in innovative solutions for ophthalmology and dermatology. Founded in 1993, the company has established a strong presence in Europe, North America, and Asia, focusing on advanced laser systems and imaging technologies. With a commitment to enhancing patient care, Quantel Medical offers a range of unique products, including the renowned "Echopulse" and "Sapphire" laser systems, which are designed to provide precise and effective treatments. The company is recognised for its dedication to research and development, achieving significant milestones in the field of medical lasers. As a trusted name in the industry, Quantel Medical has garnered numerous accolades for its cutting-edge technology and exceptional service, solidifying its position as a key player in the global healthcare market.
DitchCarbon Score
How does Quantel Medical SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Quantel Medical SAS's score of 29 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Quantel Medical SAS, headquartered in France, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Lumibird SA, which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Quantel Medical SAS. The absence of emissions data suggests that Quantel Medical SAS may be in the early stages of developing its sustainability strategy or reporting framework. However, as part of the Lumibird SA corporate family, it may align with broader initiatives and targets set by its parent company. For organisations in the medical technology sector, addressing carbon emissions is increasingly critical, and many are adopting science-based targets to mitigate their environmental impact. While specific initiatives or commitments from Quantel Medical SAS are not detailed, the industry context indicates a growing emphasis on sustainability and carbon reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Quantel Medical SAS is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
